Table 3.
Preliminary data on baseline patients' characteristics
| Cohort patients, N(%) | |
|---|---|
| N | 1074 |
| Age* | 62 (50, 73) |
| Male | 662 (62) |
| Race | 1074 |
| White | 813 (76) |
| Aboriginal | 81 (8) |
| East Asian | 47 (4) |
| South Asian | 42 (4) |
| Other | 91 (8) |
| Marital status | 937 |
| Married | 581 (62) |
| Single | 163 (17) |
| Divorced | 104 (11) |
| Widow | 89 (9) |
| BMI, kg/m2* | 26 (22, 31) |
| Cause of ESRD | 916 |
| Diabetic nephropathy | 380 (41.5) |
| Glomerulonephritis | 154 (16.8) |
| Hypertensive/ischemic renal disease | 68 (7.4) |
| Polycystic kidney disease | 49 (5.3) |
| Other | 265 (28.9) |
| Comorbidity | |
| Arrhythmia | 214 (20.9) |
| Cancer | 156 (14.4) |
| Cerebrovascular disease | 130 (12.7) |
| Congestive heart failure | 202 (20.2) |
| Chronic lung disease | 125 (12.7) |
| Claudication | 131 (13.3) |
| Coronary disease | 481 (46.7) |
| Dementia | 28 (2.8) |
| Diabetes mellitus | 515 (50.7) |
| Diabetic retinopathy | 224 (23) |
| HBV | 30 (2.9) |
| HCV | 39 (3.8) |
| HIV | 2 (.2) |
| Hypertension | 785 (86.5) |
| Pericarditis | 27 (2.7) |
| Peripheral neuropathy | 239 (24.2) |
| Peripheral vascular disease | 209 (20.6) |
| Prior cardiac arrest | 20 (2) |
| Psychiatric illness | 148 (15) |
| Seizure disorder | 34 (3.4) |
| ECG | 310 (28.7) |
| Normal | 61 (5.6) |
| Abnormal | 142 (13.1) |
| No result | 107 (9.9) |
| ECHO | 320 (29.6) |
| Normal | 14 (1.3) |
| Abnormal | 50 (4.6) |
| No result | 256 (23.7) |
| Current Smoker | 154 (15.7) |
| CLINICAL MANAGEMENT | |
| Satellite HD unit€ | 201 (18.7) |
| Type of access | 510 |
| AVF | 138 (27.1) |
| PTFE | 10 (2) |
| Non tunnel CVC | 42 (8.2) |
| Tunnel CVC | 308 (60.4) |
| LABORATORY MEASURES* | |
| Albumin, g/L | 34 (30, 37) |
| Calcium, mmol/L | 2.2 (2, 2.3) |
| Calcium X phosphate, mmol2/L2 | 3.6 (2.9, 4.5) |
| Creatinine, μmol/L | 534 (424, 682) |
| Ferritin, μg/L | 252 (136, 472) |
| Hemoglobin, g/L | 99 (89, 109) |
| Phosphate, mmol/L | 1.6 (1.2, 1.9) |
| PTH, pmol/L | 26.2 (10.7, 45.8) |
| Transaturation, % | 24 (17, 31) |
| Urea, mmol/L | 18.6 (14.6, 23.5) |
| Kt/V | 1.4 (1.2, 1.7) |
| Distance to Nephrologist, km | 482 |
| ≤50 | 387 (80.3) |
| 51 - 100 | 43 (8.9) |
| 101 - 200 | 30 (6.2) |
| > 200 | 33 (6.8) |
*Median (interquartile range)
€all clinics outside of Edmonton, Calgary and Vancouver considered satellite unit
HD Hemodialysis; BMI body mass index; ESRD end-stage renal disease; HBV Hepatitis B virus; HCV Hepatitis C virus; HIV Human immunodeficiency virus; ECG electrocardiogram; ECHO echocardiogram; AVF Arterial Venous Fistula; PD Peritoneal dialysis; PTFE Polytetrafluoroethylene; CVC Central venous catheters; PTH parathyroid hormone